Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Optase Intense (marketed as OPTASE Dry Eye Intense Drops) is a preservative-free, over-the-counter (OTC) ophthalmic lubricant designed to alleviate moderate to severe symptoms of dry eye disease, such as burning, irritation, and discomfort. The formulation contains 0.2% glycerin as the active ingredient, which functions as a humectant and lubricant to retain moisture on the ocular surface. It also incorporates high-molecular-weight sodium hyaluronate as an inactive ingredient to enhance the solution's rheological properties, thereby improving tear film stability and providing prolonged protection to the corneal epithelium. Developed and marketed by Scope Health, the product is compatible with contact lenses and is available in both multi-dose preservative-free bottles and single-use vials.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Optase Intense.